This post is part of a series of point/counterpoint arguments proposed by different members of the Pixels & Pills staff. We’re strong believers that healthy arguments can yield the best solutions, and we hope that you enjoy our series. Feel free to add your own arguments in the comments section below!
by Krissy Goelz (@krisgoelz)
In The [...]
Entries Tagged as 'Opinion'
POINT/COUNTERPOINT: Should You “Cross Streams” When You’re A Social Media Professional?
January 11th, 2012 · 1 Comment · Opinion
Tags:Best Practices·digital strategy·Digital Tools·Education·Opinion·social media·Social network·social networks·strategy·technology·Trends
POINT/COUNTERPOINT: Should You “Cross Streams” When You’re A Social Media Professional?
January 10th, 2012 · No Comments · Opinion
This post is part of a series of point/counterpoint arguments proposed by different members of the Pixels & Pills staff. We’re strong believers that healthy arguments can yield the best solutions, and we hope that you enjoy our series. Feel free to add your own arguments in the comments section below!
by Jason Brandt (@jasondmg3)
As Egon [...]
Tags:Best Practices·digital strategy·Digital Tools·Education·Opinion·social media·Social network·social networks·strategy·technology·Trends
Why the Core Visual Aid is DEAD…Vive la IVA!
May 10th, 2010 · No Comments · Opinion
By Paul Harrington
R.I.P., CVA.
Friends, Romans, and countrymen, lend me your ears: I come not to praise the CVA, but to bury it.
The CVA – or Core Visual Aid – the most commonly used sales tool in the armamentarium of pharmaceutical sales is dead, dead, dead. Certainly, for decades it had served us well: it gave [...]
Tags:creativity·Design·Digital Tools·drug safety·Education·innovation·interactive·marketing·Opinion·Pharmaceutical industry·Sales
Identity Crisis: Pharma’s Corporate Logos
May 5th, 2010 · 4 Comments · Opinion
This post continues our discussion on creativity in the Pharma industry, identifying issues, highlighting case studies, and providing best practices guidelines for Pharma creatives.
By Dan V. Licht (@thedvl)
Pharma logos? Creative? I can hear you snorting from here, you know. Not very polite. And anyway, I know what you’re thinking. ”Creative? Pharma company identities? Make a dark-pastel [...]
Tags:advertising·branding·communication·creativity·Design·logo·marketing·Opinion·Trends·visual
Following Up with Amy Cowan of Google
April 12th, 2010 · 3 Comments · Opinion
We’ll be kicking off this week’s theme of “Ones to Watch” by revisiting Pixels & Pills’ interview with Google’s Amy Cowan at the ePharma Summit earlier this year.
By Jason Brandt
Last month, Pixels & Pills’ Carl Turner interviewed Amy Cowan, head of the health industry for Google at the ePharma Summit.
In her conversation with Carl, Amy [...]
Tags:advertising·Augmented reality·communication·e-pharma summit·Google·Google Health·Opinion·Video
More to Follow: Pixels & Pills’ Favorite Pharma Folks, Part II
April 5th, 2010 · 12 Comments · Knowledge
By Kimberly Reyes (@CommDuCoeur)
Last August, Pixels and Pills provided you with a handy “who’s who” list of 10 Pharma Twitterers that we can’t get enough of.
We’re calling this year “the year that everything changes” for Pharma, and with new challenges come new faces. We’ve since added some names to the list and are proud to [...]
Tags:Blogs·communication·Communities·digital strategy·Education·Health care·innovation·marketing·Opinion·Pharma·social media·Social network·technology·Thought Leaders·Trends·Twitter
Like Talking to a Wall: Why Pharma Needs to Speak Up
March 11th, 2010 · 2 Comments · News, Opinion
From Mark McCoy
There is a high level of dissatisfaction with our healthcare system these days, which makes pharma companies vulnerable to becoming a target for blame. It’s hard to believe that even though pharma companies discover and develop the drugs that advance medical treatment, the industry is so vilified that only cigarette makers and big [...]
Tags:American Board of Internal Medicine·doctors·Education·Legal Issues·Medicine·Opinion·Pharmaceutical industry·Residency
Matthew Whalen of Impact at the FDA Hearings
November 12th, 2009 · No Comments · News
Matthew Whalen of Impact was kind enough to give us his take on the FDA Hearings on Social Media.
Tags:#fdasm·communication·Communities·Compliance·digital strategy·Digital Tools·FDA·Legal Issues·Opinion·Pharma·Pharmaceutical industry·social media·Thought Leaders·Trends
Do We Need FDA Hearings on SEO & User Experience?
November 11th, 2009 · No Comments · News, Opinion
By Sven Larsen (@zemoga)
How much attention should the government be paying to social media? As the Pixels and Pills team gears up for their coverage of the FDA hearings on social media, I’ve been thinking a lot about how patients receive their information from the web. And I wonder if the FDA shouldn’t be looking [...]
Tags:communication·Compliance·Digital Tools·Education·FDA·Health care·Opinion·Patients·SEO·social media·Trends·User Experience·user needs
Little Comments, Big Privacy
May 11th, 2011 · No Comments · Opinion
(via Chuck and Beans)
By Jason Brandt (@JasonDMG3)
“Great story. Loved the last part; very moving.”
“I disagree completely – this is what’s wrong with America today!”
While adding a comment to a blog post or a news article may seem trivial, it’s part of a larger and very important story.
Interactivity – the idea that you can offer your [...]
[Read more →]
Tags:Blog·comment·communication·conversation·crowdsourcing·data·experience·Facebook·Google·information·interactivity·internet·law·membership·News·Opinion·participation·philosophy·privacy·settings·social networks·technology·Wikipedia